$RSHN Rushnet, Inc Current Status Update on the Progress Towards heliosDX Spinout and Capital Raise Through Tier 2 Regulation A
https://www.accesswire.com/706522/rushnet-inc...gulation-a
ALPHARETTA, GA / ACCESSWIRE / June 24, 2022 / RushNet, Inc (OTC PINK:RSHN), (the "Company"
is pleased to provide this update regarding progress towards its major milestones including the spinout of heliosDX and the Tier 2 Regulation A.
Rushnet, Inc. with its current subsidiaries, heliosDX, Inc. and Grandeza Healthcare Consultants, have put in tremendous efforts with its legal, accounting, and auditor partners to accomplish critical milestones to drive the company vision forward.
As a recap of what has been accomplished this year in 2022 toward the major milestones:
January ‘22 to June 1st - PCAOB audit conducted by Somerset CPA's and Advisors. Completed with a clean opinion.
March ‘22 - June 17th - Filing a Tier 2 Regulation A with the SEC which includes:
Dividend shares for RSHN shareholders with a ratio of 650 RSHN to 1 heliosDX. Approximately over 12.5 million heliosDX shares to be issued.
Spinout of heliosDX, Inc. as a separately traded entity
17,000,000 shares to be issued at discount of $1.18 per share in an attempt to raise up to $20,000,000 in capital to fund our future acquisitions
June 2nd - Submitted Audited Financials to the OTCMarkets
Week of June 13th - Retained new SEC and Corporate counsel with BMD (Brennan Manning Diamond) to work alongside our healthcare counsel at BDM
June 17th - Updated the Articles of Incorporation for Rushnet, Inc. in Colorado
June 17th - Reorganized Chattahoochee Physicians Laboratory Services LLC d.b.a heliosDX to heliosDX, Inc. in the state of Georgia.
Week of June 20, 2022 - Formed the Bylaws for heliosDX, Inc.
Week of June 20, 2022 - Filed the application to FINRA for heliosDX spinout and assignment of ticker symbol and dividend
All of these crucial steps are major accomplishments leading us towards the future vision, including acquisitions and ramping up additional services and capacity to reach future annual revenues of $50,000,000. With the Regulation A submitted for approval, we are currently accepting and reviewing funding agreements from interested funds and investors. You may reach out to the company if interested.
During the next couple of months, we will continue driving forward to complete these next steps which move us closer to the goals (all dates are estimated):
July:
3rd - Intent to sign purchase agreement for acquisition of toxicology laboratory
15th - Commencing mid-year financial audits
August:
12th - Expect to receive approvals for the Regulation A from the SEC
12th - Expect to receive approvals from FINRA for the spinout and ticker symbol
30th - Raise the initial required funds to complete the transaction of the acquisition.
August 31st - Expect to close on the acquisition of the toxicology laboratory
Our 15 month plan has been updated and can now be accessed through Prezi.
https://www.accesswire.com/706522/rushnet-inc...gulation-a
ALPHARETTA, GA / ACCESSWIRE / June 24, 2022 / RushNet, Inc (OTC PINK:RSHN), (the "Company"
is pleased to provide this update regarding progress towards its major milestones including the spinout of heliosDX and the Tier 2 Regulation A. Rushnet, Inc. with its current subsidiaries, heliosDX, Inc. and Grandeza Healthcare Consultants, have put in tremendous efforts with its legal, accounting, and auditor partners to accomplish critical milestones to drive the company vision forward.
As a recap of what has been accomplished this year in 2022 toward the major milestones:
January ‘22 to June 1st - PCAOB audit conducted by Somerset CPA's and Advisors. Completed with a clean opinion.
March ‘22 - June 17th - Filing a Tier 2 Regulation A with the SEC which includes:
Dividend shares for RSHN shareholders with a ratio of 650 RSHN to 1 heliosDX. Approximately over 12.5 million heliosDX shares to be issued.
Spinout of heliosDX, Inc. as a separately traded entity
17,000,000 shares to be issued at discount of $1.18 per share in an attempt to raise up to $20,000,000 in capital to fund our future acquisitions
June 2nd - Submitted Audited Financials to the OTCMarkets
Week of June 13th - Retained new SEC and Corporate counsel with BMD (Brennan Manning Diamond) to work alongside our healthcare counsel at BDM
June 17th - Updated the Articles of Incorporation for Rushnet, Inc. in Colorado
June 17th - Reorganized Chattahoochee Physicians Laboratory Services LLC d.b.a heliosDX to heliosDX, Inc. in the state of Georgia.
Week of June 20, 2022 - Formed the Bylaws for heliosDX, Inc.
Week of June 20, 2022 - Filed the application to FINRA for heliosDX spinout and assignment of ticker symbol and dividend
All of these crucial steps are major accomplishments leading us towards the future vision, including acquisitions and ramping up additional services and capacity to reach future annual revenues of $50,000,000. With the Regulation A submitted for approval, we are currently accepting and reviewing funding agreements from interested funds and investors. You may reach out to the company if interested.
During the next couple of months, we will continue driving forward to complete these next steps which move us closer to the goals (all dates are estimated):
July:
3rd - Intent to sign purchase agreement for acquisition of toxicology laboratory
15th - Commencing mid-year financial audits
August:
12th - Expect to receive approvals for the Regulation A from the SEC
12th - Expect to receive approvals from FINRA for the spinout and ticker symbol
30th - Raise the initial required funds to complete the transaction of the acquisition.
August 31st - Expect to close on the acquisition of the toxicology laboratory
Our 15 month plan has been updated and can now be accessed through Prezi.
